FierceBiotech

Akili inks $1B SPAC deal to take prescription video game tech public

Less than two years after scoring its first FDA clearance, Akili Interactive is betting big on its digital therapeutic technology. The Massachusetts-based company has signed a reverse-merger deal with ...
FierceBiotech

Akili cuts workforce another 40%, pivots to selling digital therapeutics over the counter

It’s been a tough year for makers of prescription digital therapeutics, many of whom have had to drastically cut staff—or even, in the case of Pear Therapeutics, completely shut down—to conserve ...
Business Wire

Akili Announces FDA Authorization of EndeavorOTC, the First FDA Clearance of a Digital Treatment for Adults with ADHD Through a Video Game

BOSTON--(BUSINESS WIRE)--Akili, Inc. (Nasdaq: AKLI), a leading digital therapeutics company, today announced U.S. Food and Drug Administration (FDA) clearance of EndeavorOTC Ⓡ (AKL-T01) as an over-the ...
Yahoo Finance

Akili, Inc.'s (NASDAQ:AKLI) market cap up US$26m last week, benefiting both individual investors who own 26% as well as insiders

If you want to know who really controls Akili, Inc. (NASDAQ:AKLI), then you'll have to look at the makeup of its share registry. With 26% stake, individual investors possess the maximum shares in the ...
STAT

Akili’s paperwork to go public lays bare the challenges ahead for digital therapeutics

Akili Interactive, the maker of a Food and Drug Administration-cleared video game to treat ADHD, has long been bullish on the tremendous potential of its technology to reach wide swaths of the ...